Skip to main content
logo
Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.885
+0.075 (1.56%)
Apr 8, 2026, 11:49 AM EDT - Market open

Abeona Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.82-3.51.413
Revenue Growth (YoY)
--147.53%-52.87%-70.00%
Cost of Revenue
3.43-1.610.45-
Gross Profit
2.4-1.90.963
Selling, General & Admin
65.0329.851917.2621.64
Research & Development
26.8134.3631.0928.9738.73
Other Operating Expenses
---1.075.6632.47
Total Operating Expenses
91.8464.2149.0351.8892.84
Operating Income
-89.45-64.21-47.14-50.92-89.84
Interest Income
5.564.252.120.430.04
Interest Expense
-3.74-4.21-0.42-0.74-3.66
Other Non-Operating Income (Expense)
158.920.44-8.7511.528.52
Total Non-Operating Income (Expense)
160.730.48-7.0511.224.9
Pretax Income
71.28-63.73-54.19-39.7-84.94
Provision for Income Taxes
0.1----
Net Income
71.18-63.73-54.19-43.48-84.94
Net Income Attributable to Preferred Dividends
---3.78-
Net Income to Common
71.18-63.73-54.19-43.48-84.94
Shares Outstanding (Basic)
53412184
Shares Outstanding (Diluted)
66412184
Shares Change (YoY)
61.12%91.99%171.96%99.65%6.24%
EPS (Basic)
1.34-1.55-2.53-5.53-21.57
EPS (Diluted)
1.01-1.55-2.53-5.53-21.57
Shares Outstanding
55.0445.6426.5217.725.89
Free Cash Flow
-84.3-58.46-37.34-43.61-69.82
Free Cash Flow Per Share
-1.27-1.42-1.75-5.55-17.73
Gross Margin
41.15%-54.14%68.18%100.00%
Operating Margin
-1536.91%--1346.71%-3600.78%-2994.53%
Profit Margin
1223.08%--1548.23%-2807.36%-2831.20%
FCF Margin
-1448.47%--1066.86%-3084.37%-2327.20%
EBITDA
-86.9-62.21-44.85-47.82-86.59
EBITDA Margin
-1493.11%--1281.34%-3382.04%-2886.20%
EBIT
-89.45-64.21-47.14-50.92-89.84
EBIT Margin
-1536.91%--1346.71%-3600.78%-2994.53%
Effective Tax Rate
0.14%0.00%0.00%0.00%0.00%
Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q